Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2013 2
2018 1
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Yachikov
Page 1
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
Rubin DT, Dotan I, DuVall A, Bouhnik Y, Radford-Smith G, Higgins PDR, Mishkin DS, Arrisi P, Scalori A, Oh YS, Tole S, Chai A, Chamberlain-James K, Lacey S, McBride J, Panés J; HIBISCUS Study Group. Rubin DT, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):17-27. doi: 10.1016/S2468-1253(21)00338-1. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798036 Clinical Trial.
The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic.
Canuti M, Monti MC, Bobbio C, Muscatello A, Muheberimana T, Baldi SL, Blasi F, Canetta C, Costantino G, Nobili A, Peyvandi F, Tettamanti M, Villa S, Aliberti S, Raviglione MC, Gori A, Bandera A; COVID-19 Network Study Group. Canuti M, et al. Front Med (Lausanne). 2023 Sep 7;10:1260950. doi: 10.3389/fmed.2023.1260950. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37746083 Free PMC article.
A clinical predictive score for mood disorder risk in low-income primary care settings.
Vöhringer PA, Jimenez MI, Igor MA, Forés GA, Correa MO, Sullivan MC, Holtzman NS, Whitham EA, Barroilhet SA, Alvear K, Logvinenko T, Kent DM, Ghaemi SN. Vöhringer PA, et al. Among authors: igor ma. J Affect Disord. 2013 Dec;151(3):1125-31. doi: 10.1016/j.jad.2013.06.056. Epub 2013 Jul 31. J Affect Disord. 2013. PMID: 23916307
Detecting mood disorder in resource-limited primary care settings: comparison of a self-administered screening tool to general practitioner assessment.
Vöhringer PA, Jimenez MI, Igor MA, Fores GA, Correa MO, Sullivan MC, Holtzman NS, Whitham EA, Barroilhet SA, Alvear K, Logvinenko T, Kent DM, Ghaemi NS. Vöhringer PA, et al. Among authors: igor ma. J Med Screen. 2013;20(3):118-24. doi: 10.1177/0969141313503954. Epub 2013 Sep 30. J Med Screen. 2013. PMID: 24080916